Trifecta Capital Advisors, LLC Bio Techne Corp Transaction History
Trifecta Capital Advisors, LLC
- $601 Billion
- Q2 2025
A detailed history of Trifecta Capital Advisors, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 25 shares of TECH stock, worth $1,469. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25Holding current value
$1,469% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TECH
# of Institutions
618Shares Held
160MCall Options Held
90KPut Options Held
14.2K-
Vanguard Group Inc Valley Forge, PA18.5MShares$1.09 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$881 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.4MShares$669 Million0.08% of portfolio
-
State Street Corp Boston, MA6.53MShares$384 Million0.02% of portfolio
-
Morgan Stanley New York, NY5.72MShares$336 Million0.02% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.31B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...